theory clinical_55_8
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  Pathogenic :: "entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  BindingPartner :: "entity ⇒ bool"
  Encodes :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Localizes :: "event ⇒ bool"
  SitesDNA :: "event ⇒ bool"
  Links :: "event ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  BRCA1 :: "entity ⇒ bool"
  InHRRepair :: "event ⇒ bool"
  InDNADamage :: "event ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Homologous :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Joining :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  InHumans :: "event ⇒ bool"
  Promotes :: "event ⇒ event ⇒ bool"
  LossPALB2 :: "entity ⇒ bool"
  Localization :: "event ⇒ bool"
  Disrupts :: "event ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  Prevents :: "event ⇒ event ⇒ bool"
  Promoting :: "event ⇒ bool"
  InHRR :: "event ⇒ bool"
  DisruptsRole :: "event ⇒ bool"
  Disruption :: "event ⇒ bool"
  PerformingRole :: "event ⇒ bool"
  Access :: "event ⇒ entity ⇒ bool"
  SitesRepair :: "entity ⇒ bool"
  Action :: "event ⇒ bool"

(* Explanation 1: A patient with a pathogenic mutation in PALB2 encodes a binding partner that localizes BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage. *)
axiomatization where
  explanation_1: "∃x y z w e1 e2 e3. Patient x ∧ Mutation y ∧ Pathogenic y ∧ PALB2 z ∧ BindingPartner w ∧ Encodes e1 ∧ Agent e1 x ∧ Agent e1 w ∧ Localizes e2 ∧ Agent e2 w ∧ Agent e2 y ∧ SitesDNA e2 ∧ Links e3 ∧ Agent e3 w ∧ Agent e3 x ∧ Agent e3 y ∧ InHRRepair e3 ∧ InDNADamage e3"

(* Explanation 2: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ RAD51 z ∧ Joining e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Via e1 z ∧ InHumans e1 ∧ Promotes e2 e1"

(* Explanation 3: Loss of PALB2 disrupts the localization of BRCA2 to sites of DNA damage, which directly prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR by disrupting its role in the repair process. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3 e4. LossPALB2 x ∧ Localization e1 ∧ BRCA2 y ∧ SitesDNA z ∧ Disrupts e2 ∧ Agent e2 x ∧ Agent e2 y ∧ To e1 y ∧ Prevents e3 e4 ∧ Promoting e4 ∧ Agent e4 y ∧ Joining e4 ∧ Molecules z ∧ Undamaged z ∧ Homologous z ∧ Repair z ∧ InHRR e4 ∧ DisruptsRole e4"

(* Explanation 4: The disruption of BRCA2 localization due to the loss of PALB2 prevents BRCA2 from performing its role in HRR, specifically in joining undamaged repair molecules, because BRCA2 cannot access the repair sites. *)
axiomatization where
  explanation_4: "∃x y z e1 e2 e3. Disruption e1 ∧ Localization e2 ∧ BRCA2 x ∧ LossPALB2 y ∧ Prevents e3 e1 ∧ Agent e3 x ∧ PerformingRole e3 ∧ InHRR e3 ∧ Joining e3 ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ Access e3 z"

theorem hypothesis:
  assumes asm: "LossPALB2 x ∧ Action e1 ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z ∧ InHRR e2"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
  shows "∀x y z e1 e2. LossPALB2 x ∧ Action e1 ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z ∧ InHRR e2 ⟶ Prevents e1 e2"
proof -
  (* From the premise, we have the known information about LossPALB2, Action, BRCA2, Molecules, Undamaged, Repair, Joining, Agent, and InHRR. *)
  from asm have "LossPALB2 x ∧ Action e1 ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z ∧ InHRR e2" <ATP>
  (* There is a logical relation Implies(D, E), which states that Loss of PALB2 disrupts the localization of BRCA2 to sites of DNA damage, and this disruption prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
  (* From explanation 3 and 4, we know that the disruption of BRCA2 localization due to the loss of PALB2 prevents BRCA2 from performing its role in HRR, specifically in joining undamaged repair molecules. *)
  (* Therefore, we can infer that the loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR. *)
  then have "Prevents e1 e2" <ATP>
  then show ?thesis <ATP>
qed

end
